The GFAP labeling intensity for the AAV-miR-129-5p-injected CRS mice was similar to that of the Ctrl group, but significantly reduced relative to the CRS-only groups (Figs 4B and 4D). The gene discussed is GFAP; the disease is congenital rubella syndrome.